Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Canaccord Genuity raised its price target on WAVE Life Sciences to $43 from $40 and kept a Buy rating after the company regained full global rights to its investigational RNA editing candidate WVE-006 from GSK. The move prompted analysts to increase revenue assumptions and prompted renewed focus on an accelerated regulatory path, while market data …
Canaccord Genuity reduced its price target for Roblox Corp. to $140 from $160 while retaining a Buy rating, pointing to potential margin strain as the platform increases infrastructure spending to support higher engagement and product diversification. The firm projects substantial year-over-year growth in daily active users, gross bookings and net …
JPMorgan trimmed its 12-month price objective for ESAB to $130 from $138 but retained an Overweight rating. The downgrade reflects the expected short-term earnings hit from ESAB’s pending $1.45 billion purchase of Eddyfi and concerns that leverage will stay at or above roughly 3x until early 2027. The firm questioned the deal multiple and described…
S&P Global Ratings warns that African governments face mounting external repayment pressures in 2026, with government external debt repayments likely to exceed $90 billion this year. The agency highlights that repayments are now more than three times larger than in 2012, and that a handful of countries - led by Egypt with $27 billion due in princip…
WarrenAI's recent assessment ranks Microsoft Corporation and NVIDIA Corporation as the two most compelling investment opportunities among the Magnificent Seven. The analysis highlights analyst price targets, projected earnings and revenue growth, and valuation metrics to support the pair's positions, emphasizing AI and cloud momentum for Microsoft …
Salesforce is trading near multi-month lows despite healthy margins, strong free cash flow, and a clear path to AI-led product monetization. Use a defined-entry trade to capture a rebound as Agentforce 360 and broader generative AI adoption begin to show through in revenue and ARR acceleration.
Minutes from the central bank's January 28 meeting show the board left the Selic rate at 15% and said it will determine the magnitude and duration of any easing cycle based on evolving economic data. Policymakers stressed maintaining restrictive policy until disinflation is consolidated and inflation expectations align with targets, while noting th…
Rosenblatt has reaffirmed a Buy rating and a $550 price objective for Fabrinet following the company's fiscal 2026 second-quarter results and guidance for the third quarter. Fabrinet reported $1.13 billion in Q2 revenue and non-GAAP EPS of $3.36, and provided Q3 revenue and EPS guidance that implies continued growth. Strength in the Telecom segment…
Raymond James' technical assessment of Newmont Corporation (NEM) identifies negative momentum, weakening relative strength versus the S&P 500, and early selling-pressure volume patterns that may herald a short-term corrective phase. The firm outlines potential support tests at the 50-day moving average near $103.65 and at $97.99, with a weekly brea…
H.C. Wainwright has reiterated a Buy rating on Wave Life Sciences (WVE) and set a $30.00 price target after the company recovered global rights to its RNA editing candidate WVE-006 from GlaxoSmithKline. The research firm points to a clearer regulatory path for alpha-1 antitrypsin deficiency (AATD) accelerated approval and notes additional analyst s…
Acadia Pharmaceuticals received a negative trend vote from the European Medicines Agency’s CHMP on its marketing application for trofinetide in Rett syndrome, prompting a likely move to a formal re-examination that could delay European approval by at least four to six months. Despite the regulatory hurdle, several analysts have reiterated Buy or Ma…
Amazon Web Services says lengthy waits to connect to Europe’s transmission networks are emerging as a principal constraint on its data center expansion plans. Company executives and industry groups are pressing EU policymakers to accelerate grid upgrades and streamline permitting as connection queues of up to seven years – compared with roughly two…
Village Farms (VFF) has been quietly shifting its earnings mix from produce toward higher-margin cannabis exports and energy operations. With a market cap near $377M, positive free cash flow last year, and an EU-GMP export win announced 01/26/2026, the risk/reward favors a tactical long over the next 45 trading days. Entry $3.27, target $4.20, stop…
Ladenburg Thalmann reduced its 12-month price target on OGE Energy to $42.50 from $43.50 and retained a Neutral rating after updating forecasts to reflect close to $800 million in additional transmission and generation project spending. The firm also acknowledged an expected accretion from a proposed battery storage project, which it did not includ…
Sable Offshore Corp. (NYSE: SBLE) saw its stock fall roughly 13% Tuesday morning after the company disclosed an "at the market" program allowing up to $250 million of common stock to be sold through designated agents. The company entered a Sales Agreement with TD Securities and Jefferies, and said the offering will proceed under an effective shelf …
TransMedics' organ care platform is set to benefit from an expanding international footprint after reports of an Italian NOP program. With a $4.58B market cap, positive free cash flow ($120.6M last reported), and heavy short interest that could amplify moves, this is a tactical long for patient traders who accept valuation risk. Entry $134.03, stop…
Massimo Group (NASDAQ:MAMO) saw its stock fall more than 50% after the company disclosed it had signed a non-binding letter of intent to acquire FST Development Company Limited. The deal - proposed to be between $27 million and $35 million - would see Massimo take 100% of FST under a pre-money equity valuation range of about $38 million to $50 mill…
Credo Technology (CRDO) has been punished since its December peak despite accelerating revenue and improving margins. The combination of strong free cash flow, an attractive enterprise-value backdrop and an oversold technical picture argues for a tactical long. This trade idea lays out an entry at $122.00, a stop at $110.00, and a $170.00 target ov…
Palladyne AI Corp. (NASDAQ: PDYN) saw its stock climb about 15% Tuesday morning after announcing a contract with a major U.S. defense prime to provide a propulsion subsystem for an existing U.S. missile system program. The Salt Lake City-based company expects the work to generate nearly $1 million in revenue in 2026, with deliverables due by the en…
BofA Securities moved Popular, Inc. (NASDAQ: BPOP) from Neutral to Buy and increased its price target to $156 from $141, citing expected sustainable mid-teens return on tangible common equity and improving credit trends. The broker also boosted its 2026 EPS estimate and highlighted stronger-than-anticipated Q4 2025 net interest margin as a key driv…
BofA Securities downgraded Figure Technology (FIGR) from Neutral to Underperform and trimmed its price objective to $42 from $43, citing valuation concerns after the stock’s post-IPO rally. FIGR currently trades at $52.31 and shows varied analyst sentiment, with several firms raising targets while BofA highlights an unusually high projected multipl…
BofA Securities has begun coverage of Akoustis Technologies (NASDAQ:AKTS), assigning a Buy rating and a $34.00 price target - a notable premium to the stock's recent trade around $21.98 and a market capitalization near $1.15 billion. The bank's analyst flagged the company's radiopharmaceutical platform, biologically de-risked targets, external part…
BofA Securities upgraded Equity LifeStyle Properties (ELS) from Neutral to Buy and raised its price target to $76 from $74 after the company reported fourth-quarter results. The firm pointed to stable Manufactured Home and Annual Recreational Vehicle revenue as primary growth drivers, while flagging continued market concern about the Seasonal and T…
BofA Securities moved Sigma Lithium Corp. (SGML) from Underperform to Neutral with a $14.00 price target after the company said it had resumed mining. The broker said the restart materially lowers the chance of further timeline delays for producing sellable volumes, but it still warns of liquidity pressure during an estimated three-month ramp and o…
BofA Securities raised its rating on Oshkosh Corporation from Underperform to Neutral and set a $149.00 price target, roughly in line with the stock's recent trading level. The upgrade reflects a view that the company’s portfolio is shifting toward steadier profit sources, lower valuation risk and the Access segment being at a trough, even as Oshko…
